| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0001400 | Intron-Intron | chr3:171763026-171763269 | chr3:172045236-172045479 | 244 nt | 0.4344 |
| hsa_FNDC3B_0001500 | Intron-Intron | chr3:171763835-171764641 | chr3:172046045-172046851 | 807 nt | 0.3928 |
| hsa_FNDC3B_0001600 | Intron-Exon-Intron | chr3:171764698-171851336 | chr3:172046908-172133546 | 255 nt | 0.4824 |
| hsa_FNDC3B_0001700 | Intron-Intron | chr3:171766698-171767041 | chr3:172048908-172049251 | 344 nt | 0.3488 |
| hsa_FNDC3B_0001800 | Intron-Exon-Intron | chr3:171767888-171851336 | chr3:172050098-172133546 | 76 nt | 0.4079 |
| hsa_FNDC3B_0001900 | Intron-Intron | chr3:171768438-171782583 | chr3:172050648-172064793 | 250 nt | 0.3200 |
| hsa_chr3_0364900 | Intergenic-Intergenic | chr3:171769579-171770606 | chr3:172051789-172052816 | 1028 nt | 0.4232 |
| hsa_chr3_0365000 | Intergenic-Intergenic | chr3:171770117-171770462 | chr3:172052327-172052672 | 346 nt | 0.4798 |
| hsa_FNDC3B_0002000 | Intron-Intron | chr3:171770444-171770616 | chr3:172052654-172052826 | 173 nt | 0.4682 |
| hsa_chr3_0365100 | Intergenic-Intergenic | chr3:171771901-171775194 | chr3:172054111-172057404 | 250 nt | 0.3200 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].